MY-5445

1-(3-氯苯胺基)-4-苯基酞嗪

MY 5445;MY5445;1-(3-氯苯胺基)-4-苯基酞嗪

GSK-650394

2-环戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸

2-环戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸

SCH772984

(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺

(R)-1-(2-2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H-5INDAZOL-基)吡咯烷-3-甲酰胺;1-(2-氧代-2-(4-(4-(嘧啶-2-基)苯基)哌嗪-1-基)乙基)吡咯烷-3-甲酸(R)-甲酯;(3R)-1-[2-氧代-2-[4-[4-(2-嘧啶基)苯基]-1-哌嗪基]乙基]-N-[3-(4-吡啶基)-1H-吲唑-5-基]-3-吡咯烷甲酰胺;(R)-1-(2-氧代-2-(4-(4-(2-嘧啶L)苯基)-L-哌嗪)乙基)-3-[N-(3-(4-吡啶)吲唑-5-氨基]甲酰基-吡咯烷;(R)-1-(2-氧代-2-(4-(4-(2-嘧啶L)苯基)-L-哌嗪)乙基)-3-[N-;(3R)-1-[2-氧代-2-[4-[4-(2-嘧啶基)苯基]-1-哌嗪基]乙基]-N-[3-(4-吡啶基)-1H-吲唑-5-基]-3-吡咯烷甲酰胺,一种选择性ERK1;2抑制剂;CS-1135

Salidroside (Rhodioloside)

红景天苷

红景天苷(红景天甙)||红景天提取物;红景天( 3 % 络塞维,1 %红景天甙);毛柳甙;红景天提取物SALIDROSIDE;红景天苷(标准品);红景天苷 2-(4-羟基苯基)乙基-Β-D-葡萄糖苷;红景天苷,来源于红景天;毛柳苷,红景天甙,红景天

Rufinamide

卢非酰胺

1-(2,6-二氟苄基)-1H-1,2,3-三氮唑-4-甲酰胺;卢非酰胺及中间体;CGP 33101;E 2080;INOVELON;RUF 331;BANZEL;E2080;CS-1134;卢非酰胺;卢非酰胺,一种钠通道阻滞剂;鲁芬酰胺杂质

Ro 31-8220 Mesylate

RO-31-822

CS-1132;RO 31-8220 METHANESULFONATE;BISINDOLYLMALEIMIDE IX MESYLATE;RO318220;双吲哚马来酰亚胺 IX 甲烷磺酸盐;RO31-8220 MSOH盐

R428

1-(6,7-二氢-5H-苯并[6,7]环庚烷并[1,2-C]哒嗪-3-基)-N3-[(7S)-6,7,8,9-四氢-7-(1-吡咯烷基)-5H-苯并环庚烯-2-基]-1H-1,2,4-三唑-3,5-二胺

1-(6,7-二氢-5H-苯并[6,7]环庚烷并[1,2-C]哒嗪-3-基)-N3-[(7S)-6,7,8,9-四氢-7-(1-吡咯烷基)-5H-苯并环庚烯-2-基]-1H-1,2,4-三唑-3,5-二胺;BGB-324,CPDB1725;CS-1130;BEMCENTINIB (R428);R-428;R 428;BGB-324;BGB 324;R428,一种高效的具有选择性的AXL 抑制剂;1-(6,5-二胺

1-(2,4-DICHLOROPHENYL)-5-(4-IODOPHENYL)-4-METHYL-N-4-MORPHOLINYL-1H-PYRAZOLE-3-CARBOXAMIDE

1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-吗啉-1H-吡唑-3-甲酰胺

1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-吗啉-1H-吡唑-3-甲酰胺;1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-4-吗啉基-1H-吡唑-3-甲酰胺;AM281;AM-281;CS-1127

SB 222200

3-甲基-2-苯基-N-((1S)-1-苯基丙基)喹啉-4-甲酰胺

SB-222200;SB222200;3-甲基-2-苯基-N-((1S)-1-苯基丙基)喹啉-4-甲酰胺

U 0126-U 126

1,4-二氨基-2,3-二氰基-1,4-双(邻氨基苯巯基)丁二烯

1,4-二氨基-2,3-二氰基-1,4-双(邻氨基苯巯基)丁二烯;1,4-双(邻氨基苯硫基)丁二烯

R1530

5-(2-氯苯基)-7-氟-1,2-二氢-8-甲氧基-3-甲基吡唑并[3,4-B][1,4]苯并二氮杂卓

5-(2-氯苯基)-7-氟-1,2-二氢-8-甲氧基-3-甲基吡唑并[3,4-B][1,4]苯并二氮杂卓;R 1530;R-1530;CS-1111

LY2140023 (LY404039)

(1R,4S,5S,6S)-4-氨基-2-硫杂双环[3.1.]己烷-4,6-二甲酸 2,2-二氧化物

(1R,4S,5S,6S)-4-氨基-2-硫杂双环[3.1.0]己烷-4,6-二甲酸 2,2-二氧化物;LY404039CAS:635318-11-5;LY 404039;LY404039;CS-1104;POMAGLUMETAD;LY2140023

LGK-974

2',3-二甲基-N-[5-(2-吡嗪基)-2-吡啶基]-[2,4'-联吡啶]-5-乙酰胺

2',3-二甲基-N-[5-(2-吡嗪基)-2-吡啶基]-[2,4'-联吡啶]-5-乙酰胺;LGK974;LGK 974;NVP-LGK974;LGK974;LGK-974;CS-1102;LGK974 (WNT974)

KN-93

N-[2-[N-(4-氯肉桂)-N-甲基氨基]苯基]-N-(2-羟乙基)-4-甲氧苯磺酰胺磷酸酯盐

N-[2-[[[3-(4-氯苯基)-2-丙烯-1-基]甲基氨基]甲基]苯基]-N-(2-羟基乙基)-4-甲氧基苯磺酰胺;N-[2-[[[(E)-3-(4-CHLOROPHENYL)PROP-2-ENYL]-METHYLAMINO]METHYL]PHENYL]-N-(2-HYDROXYETHYL)-4-METHOXYBENZENESULFONAMIDE;N-[2-[[[3-(4-氯苯基)烯丙基](甲基)氨基]甲基]苯基]-N-(2-羟乙基)-4-甲氧基苯磺酰胺;N-[2-[N-(4-氯肉桂)-N-甲基氨基]苯基]-N-(2-羟乙基)-4-甲氧苯磺酰胺磷酸酯盐;KN-93;KN 93;KN93;N-[2-[N-(4-氯肉桂)-N-甲基氨基]苯基]-N-(2-羟乙基)-4-甲氧苯磺酰胺磷酸酯盐 100MG;CS-1099;CA2+;钙调蛋白依赖性激酶Ⅱ(CA2+;CAM PKⅡ)竞争性抑制剂KN-3

irbesartan

厄贝沙坦

2-丁基-3-[4-[2-(1H-四唑-5-基)苯基]苄基]-1,3-二氮杂螺-[4.4]壬-1-烯-4-酮;厄贝沙坦;2-丁基-3-[邻-1H-5-四唑基苯基]苄基]-1,3-二氮杂螺[4,4]壬-1-烯-4-酮;伊贝沙坦;依贝沙坦;安普诺维膜衣锭;AVAPRO;SR-47436;BMS-186295;CS-1098

N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]urea

N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]-2-甲氧基苯基]-N'-[1-(2-噻唑基)乙基]脲

KI20227;KI-20227;KI 20227;CS-1094;KI20227;KI 20227;N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]-2-甲氧基苯基]-N'-[1-(2-噻唑基)乙基]脲

CX-6258

(Z)-5-CHLORO-3-((5-(3-(4-METHYL-1,4-DIAZEPANE-1-CARBONYL)PHENYL)FURAN-2-YL)METHYLENE)INDOLIN-2-ONE.HCL

(3E)-5-氯-3-[[5-[3-[(六氢-4-甲基-1H-14-二氮杂革-1-基)羰基]苯基]-2-呋喃]亚甲基]-1,3-二氢-2H-吲哚-2-酮;(3E)-5-氯-3-[[5-[3-[(六氢-4-甲基-1H-1,4-二氮杂卓-1-基)羰基]苯基]-2-呋喃基]亚甲基]-1,3-二氢-2H-吲哚-2-酮

N1-(4-BUTYL-2-METHYLPHENYL)ACETAMIDE

N-(4-丁基-2-甲基苯基)乙酰胺

N-(4-丁基-2-甲基苯基)乙酰胺

Filgotinib

N-[5-[4-[(1,1-二氧代-4-硫代吗啉基)甲基]苯基][1,2,4]三唑并[1,5-A]吡啶-2-基]环丙烷甲酰胺

GLPG0634;GLPG 0634;GLPG0634;GLPG 0634;FILGOTINIB;CS-1083;N-[5-[4-[(1,1-二氧代-4-硫代吗啉基)甲基]苯基][1,2,4]三唑并[1,5-A]吡啶-2-基]环丙烷甲酰胺;FILGOTINIB (GLPG0634)无结构图

GBR-12935 di hydrochloride

1-(2-(BENZHYDRYLOXY)ETHYL)-4-(3-PHENYLPROPYL)PIPERAZINE.2HCL

GBR 12935双盐酸盐;1-[2-(二苯基甲氧基)乙基]-4-(3-苯基丙基)哌嗪二盐酸盐